K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study is an open and single-center Phase I clinical research on patients with advanced
pancreatic cancer, for evaluating their adverse reactions or tolerance to K-001, so as to
determine the safe and reasonable dosage and dosing regimen.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine